IanoÈ™, R.D.; Pop, C.; Iancu, M.; Rahaian, R.; Cozma, A.; Procopciuc, L.M.
Diagnostic Performance of Serum Biomarkers Fibroblast Growth Factor 21, Galectin-3 and Copeptin for Heart Failure with Preserved Ejection Fraction in a Sample of Patients with Type 2 Diabetes Mellitus. Diagnostics 2021, 11, 1577.
https://doi.org/10.3390/diagnostics11091577
AMA Style
IanoÈ™ RD, Pop C, Iancu M, Rahaian R, Cozma A, Procopciuc LM.
Diagnostic Performance of Serum Biomarkers Fibroblast Growth Factor 21, Galectin-3 and Copeptin for Heart Failure with Preserved Ejection Fraction in a Sample of Patients with Type 2 Diabetes Mellitus. Diagnostics. 2021; 11(9):1577.
https://doi.org/10.3390/diagnostics11091577
Chicago/Turabian Style
Ianoș, Raluca D., Călin Pop, Mihaela Iancu, Rodica Rahaian, Angela Cozma, and Lucia M. Procopciuc.
2021. "Diagnostic Performance of Serum Biomarkers Fibroblast Growth Factor 21, Galectin-3 and Copeptin for Heart Failure with Preserved Ejection Fraction in a Sample of Patients with Type 2 Diabetes Mellitus" Diagnostics 11, no. 9: 1577.
https://doi.org/10.3390/diagnostics11091577
APA Style
IanoÈ™, R. D., Pop, C., Iancu, M., Rahaian, R., Cozma, A., & Procopciuc, L. M.
(2021). Diagnostic Performance of Serum Biomarkers Fibroblast Growth Factor 21, Galectin-3 and Copeptin for Heart Failure with Preserved Ejection Fraction in a Sample of Patients with Type 2 Diabetes Mellitus. Diagnostics, 11(9), 1577.
https://doi.org/10.3390/diagnostics11091577